Senseonics HoldingsSENS +3.48%60 Days Payable is 69.30 as of Mar. 2026, which is 21% above its 10-year median of 57.06. GuruFocus rates SENS with a GF Score™ of 60/100 and a GF Value™ of $13.99 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 53.33% on this metric.
The historical rank and industry rank for Senseonics Holdings's Days Payable or its related term are showing as below:
SENS'
s Days Payable Range Over the Past 10 Years
Min: 21.68 Med: 57.06 Max: 1697.8
Current: 65.3
During the past 12 years, Senseonics Holdings's highest Days Payable was 1697.80. The lowest was 21.68. And the median was 57.06.
SENS's Days Payable is ranked worse than 53.33% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs SENS: 65.30
Senseonics Holdings's Days Payable
increased
from Mar. 2025 (50.04) to Mar. 2026 (69.30).
It may suggest that Senseonics Holdingsdelayed paying its suppliers.
Senseonics Holdings Days Payable Related Terms
Senseonics Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Senseonics Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Senseonics Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senseonics Holdings (SENS) has a Days Payable of 69.30 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Senseonics Holdings and its competitors. This is 21% above median its historical median of 57.06. Over the past decade, Senseonics Holdings' Days Payable has ranged from 21.68 to 1,697.80. According to the industry distribution chart, Senseonics Holdings ranks #424 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Senseonics Holdings' Days Payable too high?
Senseonics Holdings' current Days Payable of 69.30 is 21% above median its 10-year median of 57.06. Over the past 10 years, this metric has ranged from a low of 21.68 to a high of 1,697.80. The Medical Devices & Instruments industry median Days Payable is 68.07. Senseonics Holdings' value of 69.30 is 1.8% above this industry median. Based on the distribution chart, Senseonics Holdings ranks #424 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Senseonics Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Days Payable compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #424 out of 795 companies for Days Payable. This places Senseonics Holdings in the lower half of its industry. The industry median Days Payable is 68.07. Senseonics Holdings' value of 69.30 is 1.8% above this benchmark. Historically, Senseonics Holdings' own Days Payable has ranged from 21.68 to 1,697.80 over the past decade. While the company's 10-year median is 57.06 vs. the industry median of 68.07, Senseonics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senseonics Holdings's current Days Payable of 69.30 is 1.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current Days Payable is 69.30, which is 21% above median its own 10-year median of 57.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $13.99, compared to a current price of $5.94 — trading 57.5% below its estimated fair value. The current Days Payable is 69.30, which is 21% above median its 10-year median of 57.06 and 1.8% above the Medical Devices & Instruments industry median of 68.07. Senseonics Holdings' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Days Payable is 69.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.94 is trading 57.5% below its estimated GF Value™ of $13.99.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
Days Payable: 69.30 (21% above median its 10-year median of 57.06)
GF Value™: $13.99 vs. price of $5.94 (57.5% below fair value)
Industry Position: 1.8% above the Medical Devices & Instruments median (#424 of 795)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
60GF Score
Get the complete analysis for SENS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
